Ipamorelin – 10mg

Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue receptor (GHS-R1a) agonist. The most receptor selective GHRP in the research literature, distinguished from GHRP-2 and Hexarelin by its highly targeted activity profile that produces GH secretion with minimal influence on other pituitary hormones. iLab Pharma’s formulation supplies 10mg as a lyophilized vial, preserving peptide structural integrity and potency across storage conditions until reconstitution, standard practice for GHRPs where aqueous stability at ambient temperature is limited.

Ipamorelin’s defining research characteristic is its exceptional selectivity within the GHRP family. Where GHRP-2 produces dose dependent increases in cortisol and prolactin alongside GH secretion, and Hexarelin carries additional CD36 cardiac receptor activity, Ipamorelin stimulates GH release through GHS-R1a activation with documented minimal effect on cortisol, prolactin, ACTH, or aldosterone secretion at research relevant doses. This selectivity makes Ipamorelin the preferred reference compound in research specifically examining isolated GHS-R1a mediated GH secretion. Protocols where cortisol and prolactin elevation from less selective GHRPs would introduce confounding hormonal variables into the research endpoint analysis.

Ipamorelin is the most frequently studied GHRP in combination with GHRH analogues, particularly CJC-1295. Due to its clean selectivity profile making the combined GH response attributable primarily to the synergistic GHRH and GHS-R1a pathway co activation rather than secondary hormonal effects. The combination of a GHRH analogue stimulating pituitary GHRH receptors and Ipamorelin suppressing somatostatin tone while directly activating GHS-R1a produces a synergistic GH secretory response documented as substantially exceeding either compound administered alone. CSD stocks Ipamorelin alongside GHRP-2, Hexarelin, and Tesamorelin in the growth hormone secretagogue range. Giving researchers access to GHRPs across multiple selectivity profiles and a GHRH receptor agonist for complete GH axis stimulation research coverage from a single verified Canadian supplier.

iLab Pharma formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and iLab Pharma’s Ipamorelin meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched alongside CJC-1295 and Tesamorelin in comparative GH secretagogue combination and GHS-R1a selectivity studies. Browse CSD’s full peptide range for complete sourcing.